Mark A. Collins's Insider Trades & SAST Disclosures
Mark A. Collins's most recent trade in Renovaro Biosciences Inc was a trade of 120,968 Option to purchase shares of common stock done . Disclosure was reported to the exchange on Nov. 4, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Mark A. Collins.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Renovaro Biosciences Inc | Mark A. Collins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Nov 2024 | 120,968 | 120,968 | - | - | Option to purchase shares of common stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges